Global Single-Use Equipment for Biopharmaceutical market is projected to expand at a CAGR of 13.4% during the forecast period.
Low value related to operations and construction is recognized because the key issue stimulating the sales of and demand for disposable merchandise. Single-use solutions have created important inroads at numerous biomanufacturing stages as a reliable and cost-efficient alternative. additionally, integration of single-use technology (SUTs) in continuous bioprocess engineering is anticipated to fuel the usage of disposables.
Rising pressure to fulfil the growing demand for biopharmaceuticals is anticipated to considerably impact the adoption of SUTs among the bioprocessing industry. Hence, this space is also expected to be benefitted by the rapid growth of biologics. Moreover, SUT helps in enhancing operational capacity, that successively, prompts biopharmaceutical companies to adopt disposable equipment.
The Single-Use Equipment for Biopharmaceutical market is segmented on the lines of its Product, End User, application and regional. The basis of Product the market is segmented into Single-use Bioreactors (SUBs), Membrane Adsorbers, Mixing, Tangential Flow Filtration, Tubing, Connectors, Preassembled Tubing and Rigging, Depth Filtration and Buffer Containers. Based on End User the global Single-Use Equipment for Biopharmaceutical market covers Hospital, Clinic and Other. The Single-Use Equipment for Biopharmaceutical market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, and Rest of World. Each geographic market is further segmented to provide market revenue for selected countries such as the U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.
Competitive Rivalry
GE Healthcare, Merck Millipore, 3M, Progenics Pharmaceuticals, Patheon, Eppendorf, Advanced Scientifics, Gore, Pall, Saint-Gobain Biopharm, Nordson and Thermo Fisher Scientific are among the major players in the global Single-Use Equipment for Biopharmaceutical market share. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Single-Use Equipment for Biopharmaceutical Market has been segmented as below:
Single-Use Equipment for Biopharmaceutical Market, By Product
Single-Use Equipment for Biopharmaceutical Market, By End User
Single-Use Equipment for Biopharmaceutical Market, By Region
The report covers:
Report scope:
The scope of the report includes a detailed study of Single-Use Equipment for Biopharmaceutical market with the reasons given for variations in the growth of the industry in certain regions.
The report covers a detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include GE Healthcare, Merck Millipore, 3M, Progenics Pharmaceuticals, Patheon, Eppendorf, Advanced Scientifics, Gore, Pall, Saint-Gobain Biopharm, Nordson and Thermo Fisher Scientific. Company profile includes assigning such as company overview, product landscape, financial overview, and recent developments.
The top company reports are intended to provide our buyers with a snapshot of the industry’s most influential players.
Reasons to Buy this Report:
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our New Reports :-
Electrophoresis Reagents Market
Transfection Reagents and Equipment Market
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.2.1. Driver 1
4.2.2. Driver 2
4.2.3. Driver 3
4.3. Restraints
4.3.1. Restraint 1
4.3.2. Restraint 2
4.4. Opportunities
4.4.1. Opportunity 1
4.4.2. Opportunity 2
4.5. Challenges
4.5.1. Challenge 1
4.5.2. Challenge 2
5. Single-Use Equipment for Biopharmaceutical Market, By Product
5.1. Key Points
5.2. Single-use Bioreactors (SUBs)
5.3. Membrane Adsorbers
5.4. Mixing
5.5. Tangential Flow Filtration
5.6. Tubing
5.7. Connectors
5.8. Preassembled Tubing and Rigging
5.9. Depth Filtration
5.10. Buffer Containers
6. Single-Use Equipment for Biopharmaceutical Market, By End User
6.1. Key Points
6.2. Hospital
6.3. Clinic
6.4. Other
7. Competitive Landscape
7.1. Introduction
7.2. Recent Developments
7.2.1. Mergers & Acquisitions
7.2.2. New Product Developments
7.2.3. Portfolio/Production Capacity Expansions
7.2.4. Joint Ventures, Collaborations, Partnerships & Agreements
7.2.5. Others
8. Company Profile
(OVERVIEW, KEY FINANCIALS, PRODUCT AND PRODUCT OFFERINGS, RELATED DEVELOPMENTS)
8.1. GE Healthcare
8.2. Merck Millipore
8.3. 3M
8.4. Progenics Pharmaceuticals
8.5. Patheon
8.6. Eppendorf
8.7. Advanced Scientifics
8.8. Gore
8.9. Pall
8.10. Saint-Gobain Biopharm
8.11. Nordson
8.12. Thermo Fisher Scientific
The Single-Use Equipment for Biopharmaceutical Market has been segmented as below:
Single-Use Equipment for Biopharmaceutical Market, By Product
Single-Use Equipment for Biopharmaceutical Market, By End User
Single-Use Equipment for Biopharmaceutical Market, By Region
SUBSCRIBE TO OUR NEWSLETTERS
